N-(tert-butoxycarbonyl)glycine → HCID 20258244, 화합물
반응식
[NH2:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[O:13][C:12](=[O:14])[C:11]2[CH:15]=[CH:16][CH:17]=[CH:18][C:10]=2[N:9]=1.[C:19]([O:23][C:24]([NH:26][CH2:27][C:28](O)=[O:29])=[O:25])([CH3:22])([CH3:21])[CH3:20]>>[C:19]([O:23][C:24]([NH:26][CH2:27][C:28]([NH:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[O:13][C:12](=[O:14])[C:11]2[CH:15]=[CH:16][CH:17]=[CH:18][C:10]=2[N:9]=1)=[O:29])=[O:25])([CH3:22])([CH3:21])[CH3:20]참가 물질
3
실험 절차
Using identical reaction conditions as described for the synthesis of the compounds of formula VII of Scheme 2 above, 480 mg (2.0 mmole) of 2-(2-aminophenyl)-3,1-benzoxazin-4-one was reacted with 525 mg (3.0 mmole) of tert-butyloxycarbonylglycine to give 170 mg of the chromatographically-homogeneous tilted compound in 60% overall yield after three cycles.
후처리
- customreaction conditions
- customto give 170 mg of the
- customoverall yield after three cycles
출처 및 근거
- ORD 기록
- ord-246ab69e470f453ba6ac0a497e68561e
- 출처 데이터셋
- uspto-grants-1985_11
- 특허 번호
- US04554272
반응 노트
불러오는 중…